Manchester Capital Management LLC Gsk PLC Transaction History

Manchester Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$42.05 - $47.77 $11,984 - $13,614	285 Added 49.65%	859 $37,000
Q4 2021 Feb 10, 2022	SELL	$38.88 - $45.31 $2,993 - $3,488	-77 Reduced 11.83%	574 $25,000
Q3 2021 Nov 12, 2021	BUY	$38.79 - $43.16 $10,473 - $11,653	270 Added 70.87%	651 $25,000
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $10,262 - $11,650	281 Added 281.0%	381 $15,000
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $34,070 - $39,940	-1,000 Reduced 90.91%	100 $4,000
Q1 2018 May 07, 2018	BUY	$36.18 - $40.15 $36,180 - $40,150	1,000 Added 1000.0%	1,100 $43,000
Q4 2017 Feb 08, 2018	SELL	$35.34 - $41.9 $35,340 - $41,900	-1,000 Reduced 90.91%	100 $4,000
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $43,384 - $45,705	1,100	1,100 $45,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Manchester Capital Management LLC with notifications on news.